Deepen

XCAD Network Empowers the Creator Economy with the Launch of $DON with YouTube Star TheDonato on Gate.io and MEXC

Source Node:
Time Stamp: May 8, 2024 7:51 AM - Modified On: May 8, 2024 - Published By:
Source Cluster:
Republished By Plato

Innovative Creator Token to Enable Content Monetisation and Enhance Fan Engagement Dubai, 8th May, 2024 – XCAD Network, a leading Watch2Earn tokenisation platform for YouTubers, today unveiled the highly anticipated addition to its innovative creator token ecosystem, $DON, in collaboration with Donato Muñoz (TheDonato), a popular YouTube star with 40M+ subscribers and 7B views recognised for exciting content about video games. The new creator token was listed on Gate.io and MEXC at 07:00 am UTC on Wednesday, 8th May 2024. Strategically positioned to capitalise on the evolving creator economy, the

GroundUp Studios Launches in Hong Kong to Re-imagine Music & Art in Web3

Source Node:
Time Stamp: May 11, 2023 5:09 AM - Modified On: May 11, 2023 - Published By:
Source Cluster:
Republished By Plato

Music label to establish a borderless community for web3 enthusiasts, musicians and artists to connect, socialize and collaborate on extraordinary multimedia art projects Use of blockchain and NFT technology unleashes artistic creativity; more equitable compensation for artists; and new opportunities in music distribution, licensing Core management team led by award-winning songwriter, recording artist and brand marketing veteran Adrian Fu, alongside seasoned professionals in entertainment, brand partnerships, technology infrastructure and fintech NFT membership access pass planned within 1H 2023 HONG KONG, May 11, 2023 - (ACN Newswire) – GroundUp Studios, a

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Source Node:
Time Stamp: November 13, 2022 3:46 AM - Modified On: November 17, 2022 - Published By:
Source Cluster:
Republished By Plato

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that